Rubicon announces eucalyptus commercialisation agreement

Rubicon announces eucalyptus commercialisation agreement in Brazil 22 November, 2018 - Rubicon announced today that ArborGen Inc ("ArborGen") has signed an agreement with Gerdau Acos Longos S.A. (Gerdau) granting ArborGen exclusive rights to develop and commercialise Gerdau's proprietary improved genetic eucalyptus clones in Brazil. The partnership will expand ArborGen's eucalyptus product offering in Brazil to include Gerdau's high wood density and high yield clones ideally suited for the charcoal and energy markets. Please refer to the attached ArborGen release for further information. About ArborGen ArborGen is the largest commercial global seedling supplier and a leading provider of advanced genetics, for the forest industry. Employing state-of-the-art technology, ArborGen is developing high-value products that significantly improve the productivity of forestry. For more information, please visit ArborGen's website at www.arborgen.com. End CA:00327200 For:RBC Type:GENERAL Time:2018-11-22 08:31:19